Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms

Background. Platinum-based chemotherapy is the mainstay of front-line treatment of patients affected by pluri-metastatic intermediate/high grade NeuroEndocrine Neoplasms (NENs). However, there are no standard second-line treatments at disease progression. Previous clinical experiences have evidenced...

Descripción completa

Detalles Bibliográficos
Autores principales: Tafuto, Salvatore, von Arx, Claudia, Capozzi, Monica, Tatangelo, Fabiana, Mura, Manuela, Modica, Roberta, Barretta, Maria Luisa, Di Sarno, Antonella, Tornesello, Maria Lina, Colao, Annamaria, Ottaiano, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723560/
https://www.ncbi.nlm.nih.gov/pubmed/31443197
http://dx.doi.org/10.3390/jcm8081224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723560/
https://www.ncbi.nlm.nih.gov/pubmed/31443197
http://dx.doi.org/10.3390/jcm8081224

Ejemplares similares